Simplex Trading’s Rockwell Medical RMTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $982 | Sell |
110
-130
| -54% | -$1.29K | ﹤0.01% | 8609 |
|
|
2025
Q4 | $2K | Sell |
240
-1,100
| -82% | -$11.1K | ﹤0.01% | 7836 |
|
|
2025
Q3 | $16K | Buy |
+1,340
| New | +$16.4K | ﹤0.01% | 7550 |
|
|
2025
Q2 | – | Sell |
-3,850
| Closed | -$43K | – | 9586 |
|
|
2025
Q1 | $43K | Sell |
3,850
-3,670
| -49% | -$66.6K | ﹤0.01% | 5928 |
|
|
2024
Q4 | $153K | Buy |
7,520
+380
| +5% | +$11.1K | ﹤0.01% | 4769 |
|
|
2024
Q3 | $283K | Buy |
7,140
+5,590
| +361% | +$150K | ﹤0.01% | 4190 |
|
|
2024
Q2 | $27K | Buy |
1,550
+140
| +10% | +$2.37K | ﹤0.01% | 6651 |
|
|
2024
Q1 | $23K | Sell |
1,410
-1,620
| -53% | -$23.6K | ﹤0.01% | 6994 |
|
|
2023
Q4 | $57K | Buy |
3,030
+2,290
| +309% | +$43K | ﹤0.01% | 5962 |
|
|
2023
Q3 | $15K | Sell |
740
-800
| -52% | -$24.3K | ﹤0.01% | 6891 |
|
|
2023
Q2 | $84K | Buy |
1,540
+1,310
| +570% | +$40.3K | ﹤0.01% | 5293 |
|
|
2023
Q1 | $4K | Buy |
+230
| New | +$3.96K | ﹤0.01% | 8212 |
|
|
2022
Q3 | – | Sell |
-720
| Closed | -$9K | – | 10739 |
|
|
2022
Q2 | $9K | Buy |
720
+452
| +169% | +$12K | ﹤0.01% | 8389 |
|
|
2022
Q1 | $13K | Buy |
+268
| New | +$11.4K | ﹤0.01% | 8676 |
|
|
2021
Q4 | – | Sell |
-2,031
| Closed | -$196K | – | 11298 |
|
|
2021
Q3 | $196K | Buy |
2,031
+3
| +0.1% | +$228 | ﹤0.01% | 5617 |
|
|
2021
Q2 | $203K | Buy |
2,028
+2,003
| +8,012% | +$207K | ﹤0.01% | 5661 |
|
|
2021
Q1 | $321K | Buy |
25
+24
| +2,400% | +$3.55K | ﹤0.01% | 4067 |
|
|
2020
Q4 | $13K | Sell |
1
-1
| -50% | -$112 | ﹤0.01% | 7259 |
|
|
2020
Q3 | $28K | Hold |
2
| – | – | ﹤0.01% | 6137 |
|
|
2020
Q2 | $38K | Sell |
2
-2
| -50% | -$472 | ﹤0.01% | 5724 |
|
|
2020
Q1 | $79K | Buy |
+4
| New | +$1.14K | ﹤0.01% | 4618 |
|
|
2019
Q4 | – | Hold |
0
| – | -$3K | – | 7869 |
|
|
2019
Q3 | – | Sell |
-1
| Closed | -$307 | – | 6824 |
|
|
2019
Q2 | $25K | Sell |
1
-2
| -67% | -$1.02K | ﹤0.01% | 5442 |
|
|
2019
Q1 | $206K | Buy |
3
+2
| +200% | +$912 | ﹤0.01% | 3579 |
|
|
2018
Q4 | $15K | Hold |
1
| – | – | ﹤0.01% | 5578 |
|
|
2018
Q3 | $56K | Hold |
1
| – | – | ﹤0.01% | 5058 |
|
|
2018
Q2 | $33K | Sell |
1
-1
| -50% | -$600 | ﹤0.01% | 5460 |
|
|
2018
Q1 | $12K | Buy |
+2
| New | +$1.26K | ﹤0.01% | 3878 |
|
|
2017
Q4 | – | Hold |
0
| – | -$14K | – | 6565 |
|
|
2017
Q3 | – | Sell |
-2
| Closed | -$1.53K | – | 3497 |
|
|
2017
Q2 | $54K | Buy |
2
+1
| +100% | +$819 | ﹤0.01% | 2328 |
|
|
2017
Q1 | $4K | Sell |
1
-3
| -75% | -$1.98K | ﹤0.01% | 4807 |
|
|
2016
Q4 | $31K | Buy |
4
+2
| +100% | +$1.38K | ﹤0.01% | 2630 |
|
|
2016
Q3 | $24K | Sell |
2
-1
| -33% | -$810 | ﹤0.01% | 2801 |
|
|
2016
Q2 | $73K | Sell |
3
-1
| -25% | -$930 | ﹤0.01% | 1721 |
|
|
2016
Q1 | $57K | Buy |
4
+3
| +300% | +$2.36K | ﹤0.01% | 1856 |
|
|
2015
Q4 | $42K | Hold |
1
| – | – | ﹤0.01% | 2066 |
|
|
2015
Q3 | $7K | Sell |
1
-2
| -67% | -$2.9K | ﹤0.01% | 3757 |
|
|
2015
Q2 | $147K | Buy |
3
+2
| +200% | +$2.54K | 0.01% | 967 |
|
|
2015
Q1 | $12K | Hold |
1
| – | – | ﹤0.01% | 2800 |
|
|
2014
Q4 | $18K | Buy |
+1
| New | +$1.03K | ﹤0.01% | 2149 |
|
Other funds holding RMTI
VCM
VFT
WANY
Simplex Trading's RMTI Position: Q1 2026 in Review
Simplex Trading sold out of Rockwell Medical (RMTI) in Q1 2026, closing a stake of 227 shares — an estimated $2.26K sold.
Simplex Trading first reported a position in RMTI in Q4 2014 and held it in 27 quarters. The position peaked at $374K in Q1 2016. 42 funds tracked by Wall St. Rank hold RMTI as of Q1 2026.
- Simplex Trading reported no remaining Rockwell Medical position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 227 Rockwell Medical shares in Q1 2026, an estimated $2.26K.
- Simplex Trading first reported a position in Rockwell Medical in Q4 2014 and held it in 27 quarters.
- Simplex Trading's Rockwell Medical position peaked at $374K in Q1 2016.
- 42 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.